Ignite Creation Date:
2025-12-26 @ 5:23 PM
Ignite Modification Date:
2026-01-24 @ 12:11 PM
Study NCT ID:
NCT03089606
Status:
COMPLETED
Last Update Posted:
2023-11-15
First Post:
2017-02-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab TX-naive Distant Mets Melanoma and Use of (C11-AMT) PET at Baseline as Imaging Biomarker
Sponsor:
UNC Lineberger Comprehensive Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Melanoma | View |
Keywords: